Vitiligo pp 73-80 | Cite as

Mixed Vitiligo

  • Alain TaïebEmail author


By definition, mixed vitiligo (MV) is the association of a characteristic segmental involvement associated usually in a second step with the onset of bilateral vitiligo patches. The association of segmental vitiligo (SV) to vitiligo/nonsegmental vitiligo (vitiligo/NSV) suggests a continuum between the two subsets which were formerly opposed. A common mode of revelation is a segment resistant to phototherapy in a patient diagnosed previously as vitiligo/NSV. Halo nevi and leukotrichia at first consultation in segmental vitiligo are risk factors for the progression of SV to MV. In addition, this progression of SV to MV carries a stronger link if the segment is initially situated on the trunk. Combined somatic mosaicism and immune dysregulation may explain the continuum SV-vitiligo/NSV in the case of MV.


  1. 1.
    Gauthier Y, Cario André M, Taïeb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res. 2003;16:322–32.CrossRefGoogle Scholar
  2. 2.
    Mulekar SV, Al Issa A, Asaad M, et al. Mixed vitiligo. J Cutan Med Surg. 2006;10:104–7.CrossRefGoogle Scholar
  3. 3.
    Schallreuter KU, Krüger C, Rokos H, et al. Basic research confirms coexistence of acquired Blaschkolinear Vitiligo and acrofacial Vitiligo. Arch Dermatol Res. 2007;299:225–30.CrossRefGoogle Scholar
  4. 4.
    Schallreuter KU, Krüger C, Würfel BA, et al. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int J Dermatol. 2008;47:743–53.CrossRefGoogle Scholar
  5. 5.
    Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, Goh BK, Anbar T, Silva de Castro C, Lee AY, Parsad D, van Geel N, Le Poole IC, Oiso N, Benzekri L, Spritz R, Gauthier Y, Hann SK, Picardo M, Taieb A, Vitiligo Global Issue Consensus Conference Panelists. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012a;25:E1–13.CrossRefGoogle Scholar
  6. 6.
    Ezzedine K, Diallo A, Léauté-Labrèze C, Seneschal J, Mossalayi D, AlGhamdi K, Prey S, Bouchtnei S, Cario-André M, Boralevi F, Jouary T, Taieb A. Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern. Arch Dermatol. 2012b;148:497–502.CrossRefGoogle Scholar
  7. 7.
    Ezzedine K, Diallo A, Léauté-Labrèze C, Séneschal J, Prey S, Ballanger F, Alghamdi K, Cario-André M, Jouary T, Gauthier Y, Taieb A. Halo nevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo. Br J Dermatol. 2012c;166:539–44.CrossRefGoogle Scholar
  8. 8.
    Schallreuter KU, Salem MA, Holtz S, Panske A. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS. FASEB J. 2013;27:3113–22.CrossRefGoogle Scholar
  9. 9.
    Van Geel N, Mollet IG, De Schepper S, et al. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res. 2010;23:375–84.CrossRefGoogle Scholar
  10. 10.
    Van Geel N, De Lille S, Vandenhaute S, et al. Different phenotypes of segmental vitiligo based on a clinical observational study. J Eur Acad Dermatol Venereol. 2011a;25:673–8.CrossRefGoogle Scholar
  11. 11.
    Van Geel N, Speeckaert R, Lambert J, et al. Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis. J Eur Acad Dermatol Venereol. 2011b;25:673–8.CrossRefGoogle Scholar
  12. 12.
    Neri I, Russo T, Piccolo V, Patrizi A. Mixed vitiligo in childhood: a study on 13 italian patients. J Eur Acad Dermatol Venereol. 2013;27:e136–47.CrossRefGoogle Scholar
  13. 13.
    Hashimoto N, Tanemura A, Yamada M, Itoi S, Katayama I. Hepatitis C-related mixed type vitiligo in a patient with Ivemark syndrome. J Dermatol. 2014;41:185–6.CrossRefGoogle Scholar
  14. 14.
    Lee DY, Kim PS, Lee JH. Mixed vitiligo treated by suction blister epidermal grafting: long-term follow up. J Dermatol (Seoul). 2009;36:672–3.CrossRefGoogle Scholar
  15. 15.
    Oiso N, Kawada A. Superimposed segmental vitiligo (mixed vitiligo) with non-segmental vitiligo and segmental vitiligo along the narrow Blaschko lines (type 1a). J Dermatol. 2016;43:1388. Scholar
  16. 16.
    Taieb A. Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res. 2000;13:41–7.CrossRefGoogle Scholar
  17. 17.
    Taïeb A, Morice-Picard F, Jouary T, et al. Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res. 2008;21:646–52.CrossRefGoogle Scholar
  18. 18.
    Koga M. Vitiligo: a new classification and therapy. Br J Dermatol. 1977;97:255–61.CrossRefGoogle Scholar
  19. 19.
    Barona MI, Arrunategui A, Falabella R, Alzate A. An epidemiologic case-control study in population with vitiligo. J Am Acad Dermatol. 1995;33:621–5.CrossRefGoogle Scholar
  20. 20.
    Parsad D, Pandhi R, Dogra S, Kumar B. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol. 2004;50:63–7.CrossRefGoogle Scholar
  21. 21.
    Ito T, Meyer KC, Ito N, Paus R. Immune privilege and the skin. Curr Dir Autoimmun. 2008;10:27–52.CrossRefGoogle Scholar
  22. 22.
    Attili VR, Attili SK. Anatomical segmentations in all forms of vitiligo: a new dimension to the etiopathogenesis. Indian J Dermatol Venereol Leprol. 2016;82:379–88.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Service de DermatologieHôpital Saint-André, CHU de BordeauxBordeauxFrance

Personalised recommendations